Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations

FN Media Group Presents USA News Group News Commentary   Vancouver, BC –November 9, 2021 – USA News Group  –  New at-home Covid tests are on the way, according to the Biden administration, which...

BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)
QDEL : 149.80 (+3.45%)
BDX : 243.61 (-0.60%)
ABT : 128.03 (+1.71%)
DGX : 156.70 (+1.13%)
Global COVID-19 Therapeutics Market Size Now Expected To Exceed $25 Billion In 2030

Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – The increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines or therapies, which will result...

LLY : 254.83 (-2.13%)
BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)
MRNA : 368.51 (+11.80%)
PFE : 52.40 (-2.96%)
MRK : 74.89 (-5.39%)
SRNE : 5.89 (-0.84%)
BioVaxys announces that CoviDTH Demonstrates Safety and Tolerability in Broad Ranging In Vivo Clinical Pathology, Immunology, and Histopathology Evaluation, Supporting Planned Clinical Development of CoviDTH

VANCOUVER, BC –  November 9, 2021 — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or “Company”), announced today that results from its in vivo animal research...

BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets

/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has broadened the patent...

BVAXF : 0.2300 (-7.93%)
BIOV.CN : 0.290 (-7.94%)
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

FN Media Group Presents USA News Group News Commentary   Vancouver, BC –October 20, 2021 – USA News Group  –  It may have its beginning for the UK travel industry, but there are signs of the end...

BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)
BDX : 243.61 (-0.60%)
QDEL : 149.80 (+3.45%)
CVS : 92.02 (+0.55%)
ABT : 128.03 (+1.71%)
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

/PRNewswire/ -- USA News Group - It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction,...

BVAXF : 0.2300 (-7.93%)
ABT : 128.03 (+1.71%)
BDX : 243.61 (-0.60%)
QDEL : 149.80 (+3.45%)
CVS : 92.02 (+0.55%)
BIOV.CN : 0.290 (-7.94%)
Are We Coming to the End of Using the PCR Covid-19 Test?

VANCOUVER – Biotech Today – It may have its beginning for the UK travel industry, but there ...

BVAXF : 0.2300 (-7.93%)
BDX : 243.61 (-0.60%)
QDEL : 149.80 (+3.45%)
CVS : 92.02 (+0.55%)
ABT : 128.03 (+1.71%)
BDX.CN : 0.750 (unch)
BIOV.CN : 0.290 (-7.94%)
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing SARS-CoV-2,...

BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)
SRNE : 5.89 (-0.84%)
MRNA : 368.51 (+11.80%)
DVAX : 16.07 (-1.53%)
INO : 7.29 (+0.55%)
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Recently, scientific reports have shown that a universal coronavirus vaccine that protects against...

BVAXF : 0.2300 (-7.93%)
MRNA : 368.51 (+11.80%)
SRNE : 5.89 (-0.84%)
DVAX : 16.07 (-1.53%)
INO : 7.29 (+0.55%)
BIOV.CN : 0.290 (-7.94%)
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine

 Vancouver, BC – October 20, 2021 – BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) (FRA:5LB) (“BioVaxys” or “Company”) announced today that it has filed with the United States Patent...

BIOV.CN : 0.290 (-7.94%)
BVAXF : 0.2300 (-7.93%)

Barchart Exclusives

2 Option Trade Ideas For AAPL This Week
Apple (AAPL) is currently rated a Strong Buy and the Barchart Technical Opinion rating for is a 100% Buy with a Strongest short term outlook on maintaining the current direction. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar